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We previously reported that an inhibition of antigen-speciﬁc Interferon-g release and cytotoxicity occurs after a
continuous infusion of an HY immunodominant peptide although this treatment is not able to cause a signiﬁcant delay
of male skin grafts rejection. In vivo administration of high doses of an HY peptide, through mini-osmotic pumps, in
naı¨ve female mice was used to study the effects on the male skin grafts rejection. A continuous infusion of 1mg of an
HY peptide induces a signiﬁcant delay of male skin graft rejection. In vitro HY-speciﬁc Interferon-g release was
inhibited adding peptide-speciﬁc suppressor cells: the ability to inhibit Interferon-g release was evident when two HY
peptides were present on the same dendritic cells indicating that the suppressor cells exert ‘‘linked-suppression’’. The
phenotype of the suppressor cells is CD8+CD28 and these cells express more CD62 ligand and FOXP3 than controls.
Suppressor cells were able to cause a signiﬁcant delay of rejection of male skin grafts when injected in naive female
mice. The inhibitory effects of these suppressor cells seem to be due to the impairment of antigen presentation; down-
regulation of B7 molecules on dendritic cells occurred. Taken all together, our data demonstrate that a continuous
infusion of an immunodominant HY peptide induces a T CD8 suppressor subset able to inhibit immune responses to
male tissues and cells.
r 2009 Elsevier GmbH. All rights reserved.
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The immune responses to minor histocompatibility
antigens (minor H Ags) can be responsible for host-vs-
graft (HvG) rejection and graft-vs-host (GvH) disease in
MHC-matched human transplantation and in animal
models (Simpson et al. 2002). Molecular identity of a
number of human and mouse minor H Ags has been
well elucidated (Simpson et al. 2002; Simpson and
Roopenian, 1997). As indicated from the detailed
genetic analysis of minor H Ags, polymorphic polypep-
tides can give rise, after their processing, to single
peptides that associate with MHC class I and II
molecules.
The HY minor H Ags are particularly subjected to
analysis because all the epitopes are encoded by genes
located on the Y chromosome, and in mice, these map to
the Sxr deletion interval (DSxr) (Simpson et al. 1997).
MHC class I- and II-restricted HY epitopes of the H-
2b haplotype have been identiﬁed (Greenﬁeld et al. 1996;
Markiewicz et al. 1998; Scott et al. 2000). The two MHC
class I-restricted peptides, WMHHNMLDI (WI) and
KCSRNRQYL (KL), originated, respectively, from the
Uty and Smcy genes, associate with the H-2Db molecule.
Some evidences suggest that the WI peptide is immu-
nodominant because T cells with speciﬁcity for H-2Db/
KL are less commonly isolated than H-2Db/WI speciﬁc
cells (Gavin et al. 1994). Further, transgenic mice
expressing a TCR speciﬁc for the KL epitope fail to
reject male skin grafts, suggesting that this receptor may
have poor reactivity for HY epitopes (Bassiri et al.
1993).
We previously reported that the continuous delivery
of soluble HY peptide WI by mini-osmotic pumps at the
dose of 0.5mg, led to a strong inhibition of antigen-
speciﬁc cytotoxic activity, Interferon (IFN)-g produc-
tion and to the priming of Interleukin (IL)-4 producing
CD8+ T cells without signiﬁcantly inﬂuencing the time
course of male skin graft rejection (Sireci et al. 1999).
The aim of the present paper was to characterize the
mechanism of hyporesponsiveness induced by the
continuous infusion of the WI peptide. Here, we report
that the administration of 1mg of peptide by mini-
osmotic pumps is able to delay signiﬁcantly male skin
graft rejection inducing antigen-speciﬁc suppressor cells.Materials and methods
Mice
Mice of the C57BL/6 (H-2b, Thy1.2) strain were
obtained from Nossan (Correzzana, Milan, Italy) while
the Thy1.1 C57BL/6 congenic mice were obtained from
The Jackson Laboratory (Bar Harbor, ME, USA). Micewere used at 8–12 weeks of age. Each experimental
group consisted of 5–10 mice.
Synthetic peptides, immunization and implantation
of mini-osmotic pumps
Sequences of the HY-Db peptides WMHHNMDLI
(WI), KCSRNRQYL (KL) and C-terminal (350–369)
20mer peptide of the 38 kDa protein of Mycobacterium
tuberculosis (p38G) with the sequence in brackets
(DQVHFQPLPPAVVSKDSALI) were synthesized by
Chem Progress, Milan, Italy. The peptides were of 90%
purity and their homogeneity was conﬁrmed by
analytical reverse phase HPLC, mass spectrometry and
amino acid composition analysis (Chem Progress,
Milan, Italy).
Female mice were immunized through a subcutaneous
injection into the hind footpads of 80 mg of the peptide
emulsiﬁed in incomplete Freund’s adjuvant (IFA)
(Difco Detroit, MI, USA). Control mice were treated
with phosphate buffered saline (PBS). Mini-osmotic
pumps (Alzet 2001, Alza Corp., Palo Alto, CA, USA)
were implanted through a 5-mm long transversal cut
made in the skin of the lumbosacral region. Pump ﬂow
regulator pointed cranially. The wound was then closed
with stitches. 0.5 or 1mg of WI peptide dissolved in
200 ml of sterile PBS or PBS alone were aseptically
injected in each mini-osmotic pump and the mean
pumping rate was 1 ml/h.
Popliteal lymph nodes (LN) were removed aseptically
from mice immunized with a single subcutaneous
injection of peptide dissolved in IFA 7 days after
immunization. Axillary, inguinal LN and spleens were
removed 7 days after implantation of pumps containing
1mg of WI peptide dissolved in PBS. Single cell
suspensions were prepared in RPMI 1640 (Gibco,
Grand Island, NY, USA) supplemented with 10% of
Foetal Calf Serum (FCS) (Gibco), 2mM L-Glutamine
(Gibco), 100U/ml Penicillin/Streptomycin (Gibco),
5 105 2-Mercaptoethanol (Gibco) and 10mM
HEPES (Gibco).
Bone marrow cells
Bone marrows cells were isolated from the femurs and
tibias of donor mice. The bones were excised and
cleaned of muscle and tendon and cut at the epiphysis at
each end. Bone marrows were ﬂushed out with 5ml of
RPMI/10% FCS, using a syringe with a 25 gauge
needle. From total bone marrow cells, dendritic cells
(DC) were obtained by plastic adherent fraction
incubating bone marrow cells on FCS covered Petri
dishes for 2 h at 37 1C in 5% CO2 atmosphere. 5 105/
ml of plastic adherent cells were cultured with 50 ng/ml
rm granulocyte monocyte-colony stimulating factor
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Fig. 1. Suppression of IFN-g production by soluble WI
induced suppressor cells. IFN-g production by WI responder
cells in co-culture with male DCs and lymphoid cells from
soluble peptide treated mice (SPT cells) at various ratio was
tested. As control of antigen-speciﬁc inhibition of IFN-g
release, responder cells obtained from draining lymph node of
G. Sireci et al. / Immunobiology 214 (2009) 703–711 705GM-CSF (BD Bioscience, San Diego, CA, USA) and
10 ng/ml rmIL-4 (BD Bioscience) for 7 days. To
promote maturation, cultures were passaged 24 h before
harvesting in culture containing tumor necrosis factor
(TNF)-a. The majority of cells in these cultures were
CD11c, CD80 and CD86 positive. Before the use,
BMDC were irradiated by a Caesium source (30Gy).
To analyze B7 expression, 2 105/ml mature BMDC, at
day 7 of culture, were cultured with 6 105/ml
CD8+CD28 or CD8+CD28+ cells. After 24 h of
incubation, DC were recovered using anti mouse
CD11c (Clone N418, hamster IgG, Serotec, Oxford,
UK) microbeads (Miltenyi, Copenhagen, Denmark) and
modulation of B7 expression was tested by CD80-FITC
mAb (Clone RMMP-1, rat IgG2a, Serotec) and CD86-
FITC mAb (Clone MCA1587, rat IgG2a, Serotec,
Oxford, UK) FACS analysis. For down-regulation
experiments, data are expressed on gated living cells
calculating by FACS software (Cell Quest) percentages
and mean ﬂuorescence intensity (MFI).mice immunized with p38G mycobacterial peptide were
exposed to p38G-pulsed DCs. Results reported are the mean
of three different experiments. *po0.005 when experimental
group was compared to WI responder+APC.IFN-c production
2 105/well draining LN cells from mice injected with
peptide emulsiﬁed in IFA were cultured in quadruplicate
with 2 104/well male APC in 96-well microtitre plates
(Nunc, Copenhagen, Denmark). In some experiments
female APC at 2 105/well were pulsed for 6 h at 37 1C
with 50 mg of peptide. After washing 2 104/well APCs
were used to stimulate IFN-g production by LN cells
from mice immunized with WI (responder cells). After
48 h of culture, supernatants were harvested and tested
for IFN-g content. IFN-g was quantiﬁed by sandwich
ELISA, using commercially available mAbs and proto-
cols recommended by PharMingen Ltd. rmIFN-g
obtained from PharMingen was used for standard curve
and the lower limit of detection was 10 pg/ml.Fig. 2. WI-suppressor cells exert linked suppression. IFN-g
levels were detected by ELISA in supernatants of co-cultures
of lymphoid cells from C57BL/6 mice treated with continuous
infusion of WI and lymph node cells from mice immunized
with WI or KL peptides dissolved in IFA and male APCs or
female APCs pulsed with WI, KL or both peptides. *po0.05
when group 3 was compared to group 1 or group 4 was
compared to group 2. FACS panels according to IFN-g
production show cell proliferation when IFN-g is produced.Co-culture and transwell assay
LN cells from mice immunized with WI (responder
cells) and lymphoid cells obtained from soluble peptide
treated (SPT) mice (mice receiving WI in soluble form
through subcutaneous implantation of miniosmotic
pumps) (SPT cells) were co-cultured with male APC in
96-well plates. Responder T cells number remained
constant (5 105/well), whereas the number of SPT cells
varied in the experiment reported in Fig. 1. SPT cells
were used at a concentration of 5 105/well in the
experiment reported in Fig. 2. In transwell assays,
responder and SPT cells were separated by a membrane
(6.5mm diameter size, 0.4 mm pore size) in 24-well plates
(Costar, Copenhagen, Denmark). In each well, respon-
der cells (8 105) were incubated in the lower compart-
ment with 8 104 APCs. In the upper compartment ofeach well, suppressor cells were incubated at 8 105.
Co-culture experiments were performed under the same
conditions without separation membrane. After 48 h,
supernatants were tested for IFN-g production. In
experiments reported in Figs. 2 and 3 responder cells
were labelled with 5,6-carboxy-2,7-dechloroﬂuorescein
(CFSE) using Oehen’s method (Oehen et al. 1997) to
ARTICLE IN PRESS
Fig. 3. In vitro and in vivo characterization of suppressor cells
phenotype. Panel A. Lymphoid cells from mice treated with
continuous infusion of WI were immunomagnetically sepa-
rated in CD8+, CD8, CD8+CD28+ and CD8+CD28.
Puriﬁcation of each fraction was checked by FACS analysis.
An equivalent number of each cell subset was co-cultured with
WI responder T cells (5 105/well) and male APC (5 104/
well). The equivalent numbers of suppressor cells were: 1 105
of CD8+, 4 105 of CD8, 5 104 of CD8+CD28+ and
5 104 of CD8+CD28 per well. After 48 h of culture,
supernatants were collected and IFN-g production was tested
by ELISA. Data reported in the ﬁgure were reproduced in
three different experiments without any signiﬁcant differences.
*po0.001 when data obtained by co-cultures containing
unsorted, CD8+ and CD8+CD28 suppressor cells were
compared with data obtained from co-cultures containing
CD8, CD8+CD28+ or medium. WI responder T cells were
labelled with CFSE and exposed to antigen in the presence of
various fractions of suppressor cells. A morphological gate was
done on responder cells to study CFSE incorporating cells in
responder T cells excluding propidium iodide positive cells.
Panel B 1 108 of unseparated, 8 107 of CD8, 1 107 of
CD8+, 5 106 of CD8+CD28+ cells and 5 106 of
CD8+CD28 cells/mouse from animals treated with contin-
uous infusion of WI, were resuspended in 0.5ml of RPMI and
injected intraperitoneally in naive female mice that were
immunized after 4 h by a single subcutaneous injection of WI
peptide in IFA. The lymph node cells, obtained after 7 days
after immunization, were cultured with irradiated male APC.
IFN-g levels were measured using ELISA method previously
reported. The same experiment was repeated three times and
no signiﬁcant differences were obtained. *po0.005.
G. Sireci et al. / Immunobiology 214 (2009) 703–711706detect dividing cells in cultures incubated with or
without suppressor cells.Cell separation
Lymphoid cells from tolerized mice were separated in
CD8 positive and negative fractions incubating the cellswith anti-mouse CD8a microbeads (Ly5, Miltenyi,
Copenhagen, Denmark) and then separated in CD8+
and CD8 fractions according to manufacturer. To
obtain CD8+CD28+ or CD8+CD28 fractions the
following procedures were used. The lymphoid cells
were incubated with CD28-FITC-conjugate mAb
(Clone MCA1363, Hamster IgG, Cedarlane, UK) for
15min at 4 1C. After washings to remove the unbound
mAb, anti-FITC multisort microbeads (Miltenyi, Co-
penhagen, Denmark) were added for 10min at 4 1C.
After washings, cells were separated in CD28+ or
CD28 fractions according to manufacturer. CD28
fraction was collected and then processed for CD8
separation. To obtain CD8+CD28+ fraction Multisort
kit was used to remove the beads. Then cells were
separated for CD8 as described above. Recovery
percentage (495%) was checked to FACS using anti-
mouse CD8a-PECy5 YTS169.4, rat IgG2b from (BD
Biosciences), after Trypan blue dye exclusion vitality
test. To study down-regulation of co-stimulatory
molecules expressed on surface of dendritic cells, only
positive fraction of immunomagnetically sorted cells
using anti-CD11c (Clone N418, hamster IgG) microbe-
ads (Miltenyi) was analyzed.Flow cytometry
CD8+CD28 and CD8+CD28+ cells from untreated
or WI SPT mice (106 in 100 ml PBS with 1% heat-
inactivated FCS and 0.02% sodium azide) were
incubated with FcBlock (Clone FCR4G8, rat IgG2b,
BD Biosciences). Stainings were assessed to compare
surface or intracellular markers FITC-labelled described
in this paragraph. CD8+CD28 and CD8+CD28+
were incubated with anti-CD62L-FITC (MEL-14, rat
IgG2a, BD Biosciences). As isotype control for compar-
ison of these surface marker expression between
CD8+CD28+ and CD8+CD28, FITC-labelled-rat
IgG2a (BD Biosciences) were used (data not shown).
To detect FOXP3 in CD8+CD28 and CD8+CD28+
cells subset mouse regulatory T Cell, Staining Kit
(eBioscience, Boston, MA, USA) with FITC-labelled-
murine FOXP3 mAb (FJK16-s, rat IgG2b, eBioscience)
was used according to manufacturer.
Before cytoﬂuorimetric analysis dendritic cells was
separated using CD11c microbeads (Miltenyi). CD11c
positive cells were stained with CD80-FITC mAb (Clone
RMMP-1, rat IgG2a, Serotec) or with CD86-FITC mAb
(Clone MCA 1587, rat IgG2a, Serotec). Controls
included cells stained with FITC-labelled rat IgG2a
(Serotec).
1 105 cells were analysed gating them by FSC versus
SSC using FACSCALIBUR and CELLQUEST soft-
ware. Every staining experiment was repeated three
times with high reproducibility of FACS analysis.
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Cells were resuspended at a density of 2 107/ml in
RPMI. An equal volume of 5 mM of CFSE (Molecular
Probes, Inc. Eugene, OR) in RPMI was added and the
cells were cultured at 37 1C for 5min. The reaction was
quenched by the addition of an equal volume of heat
inactivated FCS. Labelled cells were washed twice with
cold RPMI plus 10% heat inactivated FCS and cultured
as described in the paragraph of IFN-g production. A
morphological gate was set up excluding cells incorpor-
ating propidium iodide.
Skin grafting
Female mice were transplanted on the tail with skin
grafts obtained from the tail of naı¨ve male or female as
control. The skin grafts were protected with a 4.5-cm-long
glass pipe, which was kept on the tail for 7 days. Mice were
kept in individual cages with high-tech artiﬁcial bedding
(Omega-Dri) instead of normal sawdust. Graft survival
was followed by daily visual inspection. Scoring was
performed by comparison with syngeneic control grafts
and was based on redness, crust-forming and the presence
of hairs. Grafts were scored as rejected when they were
fully necrotic or fallen off. Positive controls received cells
from mice treated with PBS.
Recipient mice were injected the same day of
transplant with the following numbers of cells separated
by soluble WI-treated female mice: 2 107 of CD8+
CD28, 2 107 of CD8+CD28+, 2 107 of CD8+ and
5 107 of CD8. Cells resuspended in 0.5ml of RPMI
plus 10% FCS, were injected i.p. in each recipient.
Timing of injection and dose of cells were chosen after
several experiments as the best schedule to obtain
maximal inhibition of skin graft rejection.
Statistics
The double Student’s t test was used to compare
statistical signiﬁcance from experimental and control
groups. Comparative analysis of skin graft survival was
accomplished via the Kaplan–Meier cumulative survival
method and survival differences between two groups
were determined using the log-rank (Mantel–Cox) test.Results
Continuous infusion of 1mg of WI peptide was able
to delay male skin graft rejection inducing a
suppressor T cell subset
C57BL/6 female mice treated with 0.5mg of soluble
peptide show a weak delay in male skin graft rejection(4272 days), while mice treated with 1mg of WI show a
prolonged graft survival (more than 90 days) when
compared to control mice receiving PBS alone (3072
days) (data not shown). These data indicate that the
higher dose of soluble immunodominant HY-Db epitope
induced a delay of male skin graft rejection.
To test if the delayed rejection could be related to the
induction of suppressor cells, LN cells from WI-
immunized C57BL/6 mice (WI-responders) were re-
exposed to male DCs in presence of different amounts of
lymphoid cells obtained from mice treated with con-
tinuous infusion of 1mg WI-peptide. Positive controls
were obtained culturing responder T cells with male
DCs while negative controls were obtained exposing
SPT cells to male APCs. After 48 h, co-cultures super-
natants were tested for IFN-g production. Under these
experimental conditions (Fig. 1) inhibition of IFN-g
production depends on the number of SPT cells. A
strong inhibition of IFN-g production was detected at a
1:1 ratio (responder: SPT cells). The antigen-speciﬁcity
of IFN-g inhibition was demonstrated using cells from
mice immunized with peptide derived from 38Kd
protein of M. tuberculosis as responder cells stimulated
with female DC pulsed with the mycobacterial peptide
in the presence of various amounts of WI-SPT cells. No
inhibition of IFN-g release was detected with different
amounts of WI-SPT cells.
The ability of WI-speciﬁc SPT cells to inhibit IFN-g
release not only by WI- but also by KL-responder cells
was demonstrated when both WI and KL peptides were
simultaneously present on the same APC, as it happens
when APCs were obtained from male C57BL/6 or
female pulsed with both HY peptides (Fig. 2). No
inhibition of IFN-g release was detected when WI-SPT
cells were co-cultured with KL-responder and female
APCs pulsed with KL peptide (Fig. 2, line 5). Inhibition
of IFN-g production was detected when as stimulator
cells we used DCs from female mice pulsed with WI or
both HY peptides. To investigate the correlation
between IFN-g production and responder cells prolif-
eration, LN cells from WI-immunized mice labelled with
CFSE were exposed in vitro to antigen alone (male
APCs) (Fig. 2, line 1) or in presence of WI-suppressor
cells (Fig. 2, line 3). FACS panels in Fig. 3 show that
WI-immune cells without SPT cells proliferated, as the
related panel show that 41% of cells exhibited cellular
division. In the presence of SPT cells, WI-responder cells
were not able to proliferate (0.3%).WI in soluble form induces CD8+CD28 suppressor
cells and transfer suppression in naive mice
We further investigated the phenotype of antigen-speciﬁc
(SPT) suppressor cells. Immunomagnetically separated
CD8+, CD8, CD8+CD28 and CD8+CD28+ subset
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Fig. 4. CD8+CD28 regulatory cells transfer suppression to
HY in naive mice. Soluble WI-induced CD8+ (’), CD8
(J), CD8+CD28 (m) and CD8+CD28+ (n) cells, resus-
pended in 0.5ml of RPMI, were injected i.p. in female C57BL/
6 mice (10 for each experimental group) at the same day of
transplant. The numbers of the cells injected are the same
reported in the legend to Fig. 3B. The results reported were
reproduced three times without any signiﬁcant differences. The
graft survival of recipients receiving CD8+CD28 cells was
signiﬁcantly prolonged if compared with female B6 recipients
treated with CD8+CD28+ cells (log-rank test, po0.005).
G. Sireci et al. / Immunobiology 214 (2009) 703–711708fromWI-SPT cells from female mice, were co-cultured with
LN cells from WI-immunized female mice and re-exposed
to male naı¨ve APCs. As shown in Fig. 3A, a lack of IFN-g
production was evident in co-cultures containing unsepa-
rated, CD8+ and CD8+CD28 suppressor cells whereas
CD8 as well as CD8+CD28+ fractions failed to exert any
inhibitory effect on IFN-g release. FACS panels shows data
obtained with responder cells CFSE-labelled exposed to
various cell subsets. Responder cells secreting low IFN-g
levels display a CFSE-proﬁle of quiescent cells with poor
percentages of dividing cells.
To test if CD8+CD28 cells are able to transfer HY-
speciﬁc inhibition of IFN-g release, different cell
fractions obtained from mice treated with continuous
infusion of WI were injected in naive female mice that
were then immunized with WI peptide in IFA. LN cells
collected from these mice were used to secrete IFN-g
production upon in vitro antigen re-exposure, using
APCs from male mice (experimental procedure sum-
marized in the upper side of Fig. 3B).
Fig. 3B shows that LN cells collected from mice
injected with CD8+ or CD8+CD28 suppressor cells
and immunized with WI peptide, failed to produce IFN-
g when re-exposed in vitro to male APCs. Conversely,
lymphocytes collected from mice injected with CD8
and CD8+CD28+ cell subset were able to produce IFN-
g. This observation states that CD8+ and CD8+CD28
suppressor cells are able to transfer hyporesponsiveness
to HY-Db antigens in naive animals.
The ability of WI-suppressor cells to inhibit male skin
graft rejection was shown by the experiments summar-
ized in Fig. 4. Female C57BL/6 grafted with syngeneic
male skin received unseparated or separated suppressor
cells. Cell fractions were injected in naive recipients at
the same day of skin transplant. Fig. 4 shows that, as
expected, CD8 and CD8+CD28+ do not modify
appreciably the time course of rejection. About 20%
of recipients injected with CD8+ do not reject male skin,
while 50% of recipients injected at day 0 with
CD8+CD28 cells display a prolonged male graft
survival during the period of observation.Mechanisms of suppression exerted by CD8+CD28
To study the involvement of APCs in suppression
after 1 day of co-culture of APCs with suppressor cells
APCs were tested for their ability to stimulate LN cells
from WI-immune mice. APCs exposed to suppressor
cells failed to stimulate IFN-g production by WI
responder cells. Conversely, APCs co-cultured with
CD8+CD28+ obtained from mice treated with WI in
soluble form were still fully able to induce IFN-g
production by WI-immunized LN cells (Fig. 5A).
Transwell experiments were performed to verify if the
mechanism of inhibition of antigen presentation bysuppressor cells could be mediated by cell–cell contact
or by release of ‘‘suppressive’’ cytokines. As shown in
Fig. 5B, no appreciable suppressive effect was detected
when suppressor cells were cultured separately with
responder cells and APCs, suggesting a lack of involve-
ment of suppressive cytokines. Thus, suppressor cells
inhibit antigen presenting cells through cell to cell
contact.T suppressor cells overexpressed CD62L and
FOXP3 and downregulated B7 molecules on APC
Many markers of regulatory/suppressor cells were
identiﬁed (Jiang et al. 2006): intracellular FOXP3 and
surface CD62L were the more commonly identiﬁed. An
analysis of the expression of CD62 ligand and FOXP3
was done comparing the expression of these markers by
FACS analysis in CD8+CD28+ and CD8+CD28
obtained from untreated mice (Fig. 6A) with cells
obtained from mice treated with continuous infusion
of WI (Fig. 6B). To this end, CD8+ were immunomag-
netically separated from WI mini-osmotic pump treated
and untreated mice and then stained for CD8 versus
CD28, CD62L versus CD28 and FOXP3 versus CD28.
We detected higher expression of CD62L and FOXP3
(53.4% and 20.3% versus 2.1% and 3.4% in untreated
mice, respectively) in CD8+CD28 cells obtained by WI
continuous infusion. After co-culture with
CD8+CD28 suppressor T cells or CD8+CD28+ cells,
B7 molecules expression on DC, puriﬁed as positive
fraction using anti-CD11c microbeads, was analyzed.
The results described in Fig. 6C show that expression of
CD80 and CD86 decreased when DC were co-cultured
with CD8+CD28 (peaks 3 compared to peaks 1 that
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Fig. 5. CD8+CD28 impair antigen presentation through cell
to cell contact. (Panel A). IFN-g contents, detected by ELISA
from WI responder cells and male APCs, exposed to
CD8+CD28 or CD8+CD28+ cells from C57BL/6 WI mini
osmotic pump treated at the same cellular concentration
reported in Fig. 3, were shown. *po0.005 when data obtained
pre-exposing APC to CD8+CD28 were compared to pre-
exposure to CD8+CD28+ cells. Data reported are the means
of three different experiments. (Panel B). IFN-g production
detected by ELISA in trans-well plate of male APC and
responder cells from WI-immunized mice (upper part of the
well), exposed to CD8+CD28 or CD8+CD28+ cells from
C57BL/6 WI mini osmotic pump treated mice (lower part of
the well). Data reported are the means of three different
experiments.
Fig. 6. CD8+CD28 cells expression of CD62L and FOXP3.
Suppressor cells downregulate CD80 and CD86 on DC. CD8+
puriﬁed from lymphoid cells of WI mini-osmotic pump treated
(Panel B) or naı¨ve mice (Panel A) were stained with antiCD8,
antiCD28, antiCD62 ligand or antiFOXP3. Results reported
were obtained by analyzing with FACSCALIBUR living cells
gated by a morphological gate excluding propidium iodide
positive cells. Results reported were reproduced without any
signiﬁcant differences in three experiments. (Panel C) Mature
dendritic cells were exposed to CD8+CD28 (Peaks 3) or to
CD8+CD28+ (Peaks 2) or to medium (Peaks 1) for 24 h at the
same ratio reported in the legend to Fig. 3. DC were
immunomagnetically separated by anti-CD11c microbeads
(Miltenyi, Copenhagen, Denmark) and stained with antiCD80
or antiCD86. Similar results to the overlays showed were
obtained in three different experiments gating live cells by a
morphological gate excluding propidium iodide positive cells.
G. Sireci et al. / Immunobiology 214 (2009) 703–711 709are mature DC alone). A weak down-regulation of
CD80 and CD86 was detected also in DC exposed to
CD8+CD28+ (peaks 2 versus peaks 1), probably due to
a physiologic engagement of B7 molecules by CD28.
These data suggest a possible mechanism of failure of
antigen presentation exerted by CD8+CD28 cells on
the HY-speciﬁc immune response.Discussion
In this paper we analyzed the suppression of the
immune response to minor H Ags induced by a
continuous administration of an immunodominant HY
peptide in soluble form. Male skin graft survival was
signiﬁcantly prolonged when recipient female mice were
treated with 1mg but not with 0.5mg of soluble WI
before male skin transplantation (data not shown).
Data shown in Fig. 1 demonstrate that the continuous
delivery of soluble WI peptide is able to induce antigen-
speciﬁc suppressor cells. Lymphoid cells from solubleWI treated mice inhibit IFN-g release when co-cultured
with responder T cells stimulated in vitro with the same
antigen.
In our model suppressor cells exert linked suppression
(Fig. 2) as they inhibit IFN-g release also when male
DCs were used as stimulators. According to these data,
the intranasal administration of WI (Chai et al. 2004) or
the presentation of the same epitope by immature DCs
(James et al. 2002) causes a prolonged survival of
syngeneic male skin grafts. Moreover, in agreement with
Davies et al. we report that induction of tolerance to a
set of minor alloantigens under anti-CD4 and anti-CD8
treatment could also induce unresponsiveness to a
second alloantigen when it was presented by a sub-
sequent F1 graft to the tolerant animal, thus leading to
the concept of ‘‘linked suppression’’ (Davies et al. 1996).
We characterized the phenotype of the cells inhibiting
in vitro the release of IFN-g from HY immunized cells.
Only cells expressing CD8 are able to inhibit the release
of IFN-g and this activity is restricted to CD8+CD28
cells, as shown in Fig. 3A. This suppressor T cells
population expresses high levels of FOXP3 (20.3%
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(53.4% versus 2.1% detected in untreated control
animals) (Figs. 6A and B).
CD8+CD28 regulatory cells have been described in
different models of mice (Najaﬁan et al. 2003; Menager-
Marcq et al. 2006) and humans (Liu et al. 1998; Davila
et al. 2005; Baeten et al. 2006; Manavalan et al. 2004).
Relevant to our studies, increasing of CD8+CD28 T
cells observed in drug-free tolerant kidney recipients
(Baeten et al. 2006) suggests that the appearance of
CD8+CD28 T cells is a common feature in the
prolonged graft survival. Our data closely resemble
those obtained inducing prolonged survival of male skin
by intranasal administration of peptide or immature
DCs pulsed with WI (James et al. 2002; Chai et al. 2004).
It is likely that T suppressor cells inhibit antigen
presentation, as DCs exposed to CD8+CD28 fail to
present antigen when used to stimulate responder cells
(Fig. 5). This is a common way of action of regulatory/
suppressor cells described for alloantigen-speciﬁc sup-
pressor CD8+CD28 cells (Liu et al. 1998) and murine
autoantigen-speciﬁc suppressor CD8+CD28 cells (Na-
jaﬁan et al. 2003).
To test the ability of CD8+CD28 cells to induce
prolonged HY-incompatible graft survival, naive ani-
mals were injected with suppressor cells (CD8+CD28),
immunized with the same peptide and then exposed to
male DCs or naı¨ve animals injected with suppressor cells
were grafted with the male skin. The results reported in
Fig. 3B show that the passive transfer of suppressor cells
inhibits the capacity of lymphoid cells from WI-
immunized animals to release IFN-g when in vitro re-
exposed to HY antigens and causes a signiﬁcant delay of
male skin graft rejection (Fig. 4).
The mechanism of action of CD8+CD28 might be
due, at least in part, to the down-regulation of B7
molecules. This down-regulation implies that the ability
of suppressor cells to transfer hyporesponsiveness to HY
in naı¨ve animals is mediated by a lower efﬁciency of
APCs to present HY epitopes to responder cells. The
down-regulation of costimulatory molecules on APC
may prevent efﬁcient stimulation of CD4+ cells in
presence of CD8+CD28 T cells, leading to decreased
IFN-g production. Since IFN-g is known to upregulate
costimulatory molecules on APCs (Hathcock et al.
1994), it could be hypothesized that the low expression
of B7 may be the consequence of the decreased
production of IFN-g.
Moreover CD8+CD28 induced suppression inhibits
T cell activation trough a cell–cell contact and is not
mediated by ‘‘suppressive’’ cytokines (Figs. 5A and B),
according to previously reported data (Najaﬁan et al.
2003; Liu et al. 1998). It was reported (Chang et al.
2002) that CD8+CD28 alloantigen-speciﬁc suppressor
T cells induce the up-regulation of ILT3 and ILT4 on
monocytes and dendritic cells, rendering these APCstolerogenic. We cannot exclude that this mechanism of
inhibition of antigen presentation could be involved also
in our model; in fact, we’re currently testing if an up-
regulation of PIR A and PIR B (ILT3 and ILT4
equivalents in rodents) occurs in APCs exposed to
CD8+CD28 suppressor cells.
Several types of regulatory/suppressor T cells (Tregs)
have been identiﬁed and shown to play a pivotal role in
the control of autoimmunity and transplantation
tolerance in rodents and in human beings (Jiang et al.
2006). Steger et al. (2006) suggest that activation of
CD4+CD25+ regulatory T cells as the only phenotype
involved in grafts survival could be an ‘‘oversimpliﬁca-
tion’’.
We propose that the suppression described here
reﬂects a way by which suppressor T cells can function
as immunoregulatory cells in the maintenance and
establishment of peripheral hyporesponsiveness to
grafted tissues.Acknowledgments
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